• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

OTC Meds Save Billions

Article

How over-the-counter meds keep patients healthier.

Shelf of OTC medications

The availability of over-the-counter (OTC) medicines saves the U.S. healthcare system a total of $146 billion annually, according to a new study.

Specifically, cost savings due to the availability of OTC medicine came from two major categories: nearly $52 billion in drug cost savings (lower-priced OTCs versus prescription drugs) and nearly $95 billion in cost savings due to avoidance of clinical visits, according to the results of a study released by the Consumer Healthcare Products Association (CHPA).

The study examined the value created by OTC medicines to the U.S. healthcare system. The study determined the value of OTC medicines examining nine major therapeutic categories of OTC medicines, comparing cost relative to alternatives, such as prescription drugs and clinical visits. It also determined the value of OTC medicines by estimated cost savings across insurance segments (i.e., commercial plans, Medicare, Medicaid, cash) and by OTC category.

The researchers examined nine categories of the most common self-treatable conditions representing the majority of OTC medicine purchases:

  • Allergy

  • Analgesics

  • Anti-fungals (both foot and vaginal)

  • Cough/cold/flu

  • Lower gastrointestinal (GI)

  • Medicated skin (first aid and anti-itch)

  • Sleep aids

  • Smoking cessation

  • Upper GI

Related: Formulary Drug Exclusions on the Rise: What Health Execs Should Know

“OTC medicines are a cornerstone of the U.S. healthcare system,” according to David Spangler, senior vice president, policy, and general counsel at CHPA. “Without OTC medicines, 90% of consumers would seek professional medical treatment for minor ailments, causing an unnecessary burden on the healthcare system.”

In addition, the study found:

  • OTC products are a critical first line of defense against ailments, injuries and even chronic diseases, with U.S. households spending on average $442 annually on these treatments. 

  • OTC medicines provides relief for an estimated 27 million people who otherwise would not seek treatment-over 13 million Americans for allergies alone.

  • OTC medicines offer $34 billion in potential productivity benefits from avoided doctor’s office visits and time not having to be away from work for medical appointments.

Across the four categories of insurance segments within the healthcare system nearly half of the $146 billion in value was generated within the commercial market. Approximately $73.6 billion, or 50.3% of total savings, were captured by commercial plans, according to the study.

“This is particularly relevant to commercial plans and cash-based payments from high-deductible plans, as those segments gain greater value per patient compared to government-sponsored plans,” Spangler says.

While every dollar spent on OTCs yielded overall savings of $7.20, some therapeutic categories provided significantly greater savings, according to the study. For example, each medicated skin dollar provided $19 in savings, and each antifungal dollar provided over $11 in savings.

“The bottom line is that when consumers use OTC medicines to treat or relieve symptoms, they feel better and can be more productive,” Spangler says.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.